For some second-generation tau PET tracers, this specific pattern of off-target binding does not influence the diagnostic accuracy, when sampling tau pathology from different Braak regions to dissociate AD from healthy controls as it was exemplary shown for 18F-RO-948 [27]. The gene discussed is MAPT; the disease is Alzheimer disease.